The MS-STAT trial: high dose simvastatin demonstrates neuroprotection without immune-modulation in secondary progressive multiple sclerosis (SPMS) - a phase II trial

被引：0
|
作者：
Chataway, J.
Alsanousi, A.
Chan, D.
MacManus, D.
Hunter, K.
Foster, J.
Bangham, C.
Wilkie, D.
Nicholas, J.
Clegg, S.
Nielsen, C.
Scheurer, N.
Calder, V.
Greenwood, J.
Frost, C.
Nicholas, R.
机构：
[1] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Brighton & Sussex Med Sch, Brighton, E Sussex, England
[4] UCL Inst Neurol, London, England
[5] London Sch Hyg & Trop Med, London WC1, England
[6] UCL Inst Ophthalmol, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：509 / 509
页数：1
相关论文
共 50 条
  • [1] The MS-STAT Trial: A Phase II Trial of High Dose Simvastatin for Secondary Progressive Multiple Sclerosis (SPMS): Initial Results
    Chataway, Jeremy S.
    Alsanousi, Ali
    Chan, Dennis
    MacManus, David
    Hunter, Kelvin
    Foster, Jo
    Bangham, Charles
    Wilkie, David
    Nicholas, Jennifer
    Calder, Virginia
    Greenwood, John
    Frost, Chris
    Nicholas, Richard
    [J]. ANNALS OF NEUROLOGY, 2012, 72 : S111 - S111
  • [2] The MS-STAT trial: a Phase II trial of high dose simvastatin in secondary progressive multiple sclerosis
    Chataway, Jeremy
    Chan, Dennis
    Anderson, Val
    Polito, Bella
    Kallis, Constantinos
    Frost, Chris
    Calder, Virginia
    Greenwood, John
    Nicholas, Richard
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S36 - S37
  • [3] The MS-STAT trial: a randomised placebo-controlled phase II trial of high dose simvastatin in secondary progressive multiple sclerosis (SPMS)
    Chataway, J.
    Alsanousi, A.
    Chan, D.
    Macmanus, D.
    Hunter, K.
    Foster, J.
    Bangham, C.
    Wilkie, D.
    Nicholas, J.
    Calder, V.
    Greenwood, J.
    Frost, C.
    Nicholas, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 87 - 87
  • [4] THE MS-STAT TRIAL: A PHASE II TRIAL OF HIGH-DOSE SIMVASTATIN FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: BASELINE TRIAL PROFILE
    Chataway, J.
    Anderson, V.
    Chan, D.
    Frost, C.
    Hunter, K.
    Kallis, C.
    Greenwood, J.
    Schuerer, N.
    Alsanousi, A.
    Nicholas, R.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E55 - E55
  • [5] THE MS-STAT TRIAL: High Dose Simvastatin Slows Brain Atrophy and Delays Disability in Secondary Progressive Multiple Sclerosis: A Phase II Placebo-Controlled Trial
    Chataway, Jeremy
    Schuerer, Nadine
    Alsanousi, Ali
    Chan, Dennis
    MacManus, David
    Hunter, Kelvin
    Anderson, Val
    Foster, Jo
    Bangham, Charles
    Clegg, Shona
    Nielsen, Casper
    Fox, Nick
    Wilkie, David
    Nicholas, Jennifer
    Calder, Virginia
    Greenwood, John
    Frost, Chris
    Nicholas, Richard
    [J]. NEUROLOGY, 2013, 80
  • [6] MS-STAT2: A PHASE 3 TRIAL OF HIGH DOSE SIMVASTATIN IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
    Williams, E.
    John, N. A.
    Blackstone, J.
    Brownlee, W.
    Frost, C.
    Greenwood, J.
    Chataway, J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (03): : E13 - E13
  • [7] Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
    Chataway, Jeremy
    Schuerer, Nadine
    Alsanousi, Ali
    Chan, Dennis
    MacManus, David
    Hunter, Kelvin
    Anderson, Val
    Bangham, Charles R. M.
    Clegg, Shona
    Nielsen, Casper
    Fox, Nick C.
    Wilkie, David
    Nicholas, Jennifer M.
    Calder, Virginia L.
    Greenwood, John
    Frost, Chris
    Nicholas, Richard
    [J]. LANCET, 2014, 383 (9936): : 2213 - 2221
  • [8] Serum neurofilaments in secondary progressive multiple sclerosis: analysis from the ms-stat trial
    Williams, T.
    Holdsworth, K.
    Nicholas, J.
    Katsanouli, T.
    Wellington, H.
    Heslegrave, A.
    Zetterberg, H.
    Frost, C.
    Chataway, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 193 - 194
  • [9] Effect of high-dose simvastatin on cognition in secondary progressive multiple sclerosis (MS-STAT cognitive): a randomised, placebo-controlled, Phase 2 trial.
    Chan, D.
    Binks, S.
    Nicholas, J.
    Frost, C.
    Alsanousi, A.
    Fox, N.
    Wilkie, D.
    Nicholas, R.
    Chataway, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 82 - 83
  • [10] Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis From the MS-STAT Randomized Controlled Trial
    Williams, Thomas E.
    Holdsworth, Katherine P.
    Nicholas, Jennifer M.
    Eshaghi, Arman
    Katsanouli, Theodora
    Wellington, Henrietta
    Heslegrave, Amanda
    Zetterberg, Henrik
    Frost, Chris
    Chataway, Jeremy
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (02):
12345